A federal appeals court ruled unanimously Wednesday that an antitrust class action lawsuit, in which two health clinics alleged four [...] …
Blog Posts
The U.S. Department of Health and Human Services (HHS) touted the agency’s recently announced plan to pilot a 340B rebate [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
The 340B program has morphed into a battlefield of rules, audits, and reporting. For smaller covered entities (CEs), especially rural hospitals and community clinics, keeping pace feels like a losing race. While large health systems deploy entire
…
A Washington D.C. federal court this week rejected the Department of Health and Human Services’ (HHS) request to partially dismiss [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
President Donald Trump is urging more than a dozen leading pharmaceutical manufacturers to begin implementing his proposed “most-favored nation” (MFN) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Q: Tell us some interesting details about your company’s history.
Plenful was founded with a clear mission: to transform healthcare operations from the inside out. Our Founder
…
A key Senate Republican and outspoken 340B critic recently argued that any comprehensive efforts to address healthcare affordability in Congress [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A North Carolina-based drugmaker recently tightened its 340B contract pharmacy restrictions to limit distribution of a pulmonary arterial hypertension treatment—just [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Since this article was published, HRSA released new guidance on a proposed pilot rebate model. This pilot would permit manufacturers to offer 340B rebates for a limited set of drugs under defined conditions. Read more in 340B
…
AbbVie and Novartis recently became the first drugmakers to file lawsuits challenging Oregon’s new law prohibiting 340B contract pharmacy restrictions. [...] …